{
      "creators": [
        {
          "name": {
            "honourific": null,
            "family": "Najmetdinov",
            "given": "Gafur",
            "lineage": null
          }
        }
      ],
      "eprint_status": "archive",
      "publication": "South Aral Region Medical Journal; Vol. 2 No. Maxsus son-2 (2026): JANUBIY OROL BO\u2018YI TIBBIYOT JURNALI; 349-355",
      "metadata_visibility": "show",
      "userid": 1,
      "status_changed": "2026-06-16 10:02:05",
      "type": "article",
      "note": "Imported from URDTI Journal (OAI id oai:ojs2.journal.urdti.uz:article/669)",
      "full_text_status": "none",
      "id_number": "oai:ojs2.journal.urdti.uz:article/669",
      "rev_number": 1,
      "uri": "https://arxiv.universalpublishings.com/id/eprint/93273",
      "ispublished": "pub",
      "publisher": "South Aral Region Medical Journal",
      "keywords": "Rheumatoid arthritis; autoimmune disease; biological therapy; targeted therapy",
      "title": "MODERN APPROACHES TO THE TREATMENT OF RHEUMATOID ARTHRITIS",
      "abstract": "Rheumatoid arthritis is a chronic autoimmune inflammatory disease that primarily affects the joints and may lead to progressive disability if not treated appropriately. Recent advances in immunology and molecular medicine have significantly improved the understanding of disease mechanisms and contributed to the development of innovative therapeutic approaches. This article reviews modern strategies for the treatment of rheumatoid arthritis, including conventional disease-modifying antirheumatic drugs, biological therapies, and targeted synthetic agents. Particular attention is given to the importance of early diagnosis, the treat-to-target concept, individualized treatment plans, and continuous monitoring of disease activity. The findings indicate that modern therapeutic interventions effectively reduce inflammation, prevent joint destruction, improve physical function, and enhance the quality of life of patients. The study emphasizes the necessity of comprehensive and patient-centered management in achieving long-term remission and favorable clinical outcomes.",
      "date_type": "published",
      "sword_depositor": 1,
      "date": "2026-06-15",
      "lastmod": "2026-06-16 10:02:05",
      "dir": "disk0/00/09/32/73",
      "eprintid": 93273,
      "subjects": [
        "Rheumatoid arthritis",
        "autoimmune disease",
        "biological therapy",
        "targeted therapy"
      ],
      "official_url": "http://journal.urdti.uz/index/article/view/669"
    }